What's in an Apricot?: The Seeds of Life and Death

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Drescher, Gregory P.
dc.date.accessioned	2012-06-07T02:11:29Z
dc.date.issued	1995
dc.identifier.citation	Gregory P. Drescher, What's in an Apricot?: The Seeds of Life and Death(1995 Third Year Paper)	en_US
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846741
dc.description.abstract	Many complex issues arise when evaluating the ramifications of the FDA's treatment of Laetrile. While the implications of the strife created by Laetrile have much farther reaching effects regarding FDA's treatment of specialized procedures for life-threatening ailments and drugs, this paper will not explore the broader elaborate issues involving such experimental drugs or the extended history of the various products that this controversy has evolved around. Instead, this paper is limited in scope to the competing interests among the government, the doctors, the patients, and the general public, and the proper means of balancing these interests to derive the greatest benefit to all Furthermore, the relation of this controversy to the issues elicited in debates over the "right to die" and the foundational basis of death with dignity will be examined.	en_US
dc.language.iso	en_US	en
dash.license	LAA
dc.subject	Food and Drug Law	en_US
dc.subject	laetrile	en_US
dc.subject	drug availability	en_US
dc.title	What's in an Apricot?: The Seeds of Life and Death	en_US
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T02:11:29Z